PMID- 31278873 OWN - NLM STAT- MEDLINE DCOM- 20200911 LR - 20231111 IS - 1521-3773 (Electronic) IS - 1433-7851 (Print) IS - 1433-7851 (Linking) VI - 58 IP - 35 DP - 2019 Aug 26 TI - Correlating Anticancer Drug Delivery Efficiency with Vascular Permeability of Renal Clearable Versus Non-renal Clearable Nanocarriers. PG - 12076-12080 LID - 10.1002/anie.201905738 [doi] AB - Enhancing tumor targeting of nanocarriers has been a major strategy for advancing clinical translation of cancer nanomedicines. Herein, we report a head-to-head comparison between 5 nm renal clearable and 30 nm non-renal clearable gold nanoparticle (AuNP)-based drug delivery systems (DDSs) in the delivery of doxorubicin (DOX). While the two DDSs themselves had comparable tumor targeting, we found their different vascular permeability played an even more important role than blood retention in the delivery and intratumoral transport of DOX, of which tumor accumulation, efficacy, and therapeutic index were enhanced 2, 7, and 10-fold, respectively, for the 5 nm DDS over 30 nm one. These findings indicate that ultrahigh vascular permeability of renal clearable nanocarriers can be utilized to further improve anticancer drug delivery without the need for prolonged blood retention. CI - (c) 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. FAU - Peng, Chuanqi AU - Peng C AD - Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX, 75080, USA. FAU - Yu, Mengxiao AU - Yu M AD - Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX, 75080, USA. FAU - Hsieh, Jer-Tsong AU - Hsieh JT AD - Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA. FAU - Kapur, Payal AU - Kapur P AD - Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA. AD - Department of Pathology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA. FAU - Zheng, Jie AU - Zheng J AUID- ORCID: 0000-0001-8546-1882 AD - Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX, 75080, USA. AD - Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA. LA - eng GR - R01 DK103363/DK/NIDDK NIH HHS/United States GR - RP160866/CPRIT/International GR - AT-1974-20180324/Welch Foundation/International GR - 1R01DK103363/NIH NIDDK/International PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20190724 PL - Germany TA - Angew Chem Int Ed Engl JT - Angewandte Chemie (International ed. in English) JID - 0370543 RN - 0 (Antineoplastic Agents) RN - 0 (Drug Carriers) RN - 7440-57-5 (Gold) RN - 80168379AG (Doxorubicin) SB - IM MH - Animals MH - Antineoplastic Agents/*chemistry/metabolism/therapeutic use MH - Capillary Permeability MH - Doxorubicin/chemistry/metabolism/therapeutic use MH - Drug Carriers/*chemistry MH - Gold/chemistry MH - Humans MH - Hydrodynamics MH - Kidney/metabolism MH - MCF-7 Cells MH - Metal Nanoparticles/*chemistry MH - Mice MH - Microscopy, Confocal MH - Neoplasms/drug therapy/pathology MH - Particle Size MH - Tissue Distribution PMC - PMC7416736 MID - NIHMS1040956 OTO - NOTNLM OT - drug delivery OT - gold nanoparticles OT - intratumoral transport OT - therapeutic index OT - vascular permeability COIS- Conflict of interest The authors declare no conflict of interests. EDAT- 2019/07/07 06:00 MHDA- 2020/09/12 06:00 PMCR- 2020/08/26 CRDT- 2019/07/07 06:00 PHST- 2019/05/08 00:00 [received] PHST- 2019/07/03 00:00 [revised] PHST- 2019/07/07 06:00 [pubmed] PHST- 2020/09/12 06:00 [medline] PHST- 2019/07/07 06:00 [entrez] PHST- 2020/08/26 00:00 [pmc-release] AID - 10.1002/anie.201905738 [doi] PST - ppublish SO - Angew Chem Int Ed Engl. 2019 Aug 26;58(35):12076-12080. doi: 10.1002/anie.201905738. Epub 2019 Jul 24.